✨ 4 results found - Searched 22063 records in 4ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_prevalens-penyakit-paru-obstruksi-kronik-ppok-dan-emfisema-berdasark-20231122110023.jpg&width=120)
Tesis
Prevalens Penyakit Paru Obstruksi Kronik (PPOK) dan Emfisema Berdasarkan Pemeriksaan Spirometri dan Computed Tomography Scanning (CT-scan) Toraks Pada Pasien Kanker Paru di Rumah Sakit Umum Pusat Persahabatan
2019 | BY Prima Belia Fathana - Faisal Yunus - Sita Laksmi Andarini - Aziza G. Icksan- Prevalence of Chronic Obstructive Pulmonary Disease and Emphysema Based on Spirometry and Thorax CT-scan among Lung Cancer Patients Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T19279fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-dan-angka-tahan-hidup-1-tahun-kanker-paru-bukan-sel-kecil-kpkb-20231106113255.jpg&width=120)
Tesis
Profil dan Angka Tahan Hidup 1 tahun Kanker Paru Bukan Sel Kecil (KPKBSK) Jenis Adenokarsinoma Paru dengan Mutasi Epidermal Growth Factor Receptor (EGFR) Exon 20 T790M Primer di RSUP Persahabatan
2018 | BY Hapsari Retno Dewanti - Sita Laksmi Andarini - Jamal Zaini- The Characteristics and One Year Survival of Lung Adenocarcinoma Patients with Primary Exon 20 T790M Epidermal Growth Factor Receptor Mutation Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T18468fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_angka-tahan-hidup-pasien-kangker-paru-kelompok-bukan-sel-kecil-non-sku-20231019105534.jpg&width=120)
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-efikasi-dan-toksisitas-terapi-target-baru-golongan-epidermal-fa-20231018092048.jpg&width=120)
Tesis
Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type
2014 | BY Sita Laksmi Andarini - Wiendo Syah Putra Yahya - Achmad Hudoyo - Ahmad Utomo- Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
- Nomor Panggil T14533fk